Group subscription

Astragalus: From China with multiple applications

+Natural health
In print
Education

Astragalus: From China with multiple applications

December 2022

Phil Rasmussen

Thursday 1 December 2022, 01:15 AM
Astragalus
There are around 2900 astragalus species used in a variety of ways around the world [Image: iStock.com – NNehring]

Pharmacist and medical herbalist Phil Rasmussen delves into the evidence for using astragalus for a wide range of ills

Astragalus can be used as a tonic for older people or those who feel weak or fatigued, and as an immune modulator in those with chronic inflammatory a
References
  1. Chen Z, Liu L, Gao C, et al. Astragali Radix (Huangqi): A promising edible immunomodulatory herbal medicine. Journal of ethnopharmacology 2020;258:112895.
  1. Amiri MS, Joharchi MR, Nadaf M, Nasseh Y. Ethnobotanical knowledge of Astragalus spp.: The world’s largest genus of vascular plants. Avicenna J Phytomed 2020;10(2):128–42.
  1. Fu J, Wang Z, Huang L, et al. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytotherapy research 2014;28(9):1275–83.
  1. Salehi B, Carneiro J, Rocha JE, et al. Astragalus species: Insights on its chemical composition toward pharmacological applications. Phytotherapy research 2020;10.1002/ptr.6974.
  1. Abd Elrahim Abd Elkader HT, Essawy AE, Al-Shami AS. Astragalus species: Phytochemistry, biological actions and molecular mechanisms underlying their potential neuroprotective effects on neurological diseases. Phytochemistry 2022;202:113293.
  1. Su G, Chen X, Liu Z, et al. Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children. Cochrane Database Syst Rev 2016;12(12):CD011958.
  1. Yang ZC, Qu ZH, Yi MJ, et al. Astragalus extract attenuates allergic airway inflammation and inhibits nuclear factor κB expression in asthmatic mice. Am J Med Sci 2013;346(5):390–95.
  1. Matkovic Z, Zivkovic V, Korica M, et al. Efficacy and safety of Astragalus membranaceus in the treatment of patients with seasonal allergic rhinitis. Phytotherapy research 2010;24(2):175–81.
  1. Shen HH, Wang K, Li W, et al. Astragalus Membranaceus prevents airway hyperreactivity in mice related to Th2 response inhibition. Journal of ethnopharmacology 2008;116(2):363–69.
  1. Qu ZH, Yang ZC, Chen L, et al. Inhibition airway remodeling and transforming growth factor-β1/Smad signaling pathway by astragalus extract in asthmatic mice. International journal of molecular medicine 2012;29(4):564–68.
  1. Yuan X, Sun S, Wang S, Sun Y. Effects of astragaloside IV on IFN-gamma level and prolonged airway dysfunction in a murine model of chronic asthma. Planta medica 2011;77(4):328–33.
  1. Lu Y, Xing QQ, Xu JY, et al. Astragalus polysaccharide modulates ER stress response in an OVA-LPS induced murine model of severe asthma. International journal of biological macromolecules 2016;93(Pt A):995–1006.
  1. Chen SM, Tsai YS, Lee SW, et al. Astragalus membranaceus modulates Th1/2 immune balance and activates PPARγ in a murine asthma model. Biochemistry and cell biology 2014;92(5):397–405.
  1. Wang W, Jing W, Liu, Q. Astragalus Oral Solution Ameliorates Allergic Asthma in Children by Regulating Relative Contents of CD4+CD25highCD127low Treg Cells. Frontiers in pediatrics 2018;6:255.
  1. Jiang D, Wang X, Su Q, et al. Milkvetch root improves immune function in patients with acute exacerbation of COPD. Bio-medical materials and engineering 2015;26(Suppl 1):S2113–21.
  1. Wong EL, Sung RY, Leung TF, et al. Randomized, double-blind, placebo-controlled trial of herbal therapy for children with asthma. Journal of alternative and complementary medicine 2009;15(10):1091–97.
  1. Lin Y, Wang B, Luo XQ. Clinical study of astragalus’s preventing the recurrence of asthma in children. Chinese journal of integrated traditional and Western medicine 2011;31(8):1090–92.
  1. Ocampo-Piraquive V, Nieto-Aristizábal I, Cañas CA, Tobón GJ. Mortality in systemic lupus erythematosus: causes, predictors and interventions. Expert review of clinical immunology, 2018; 14(12), 1043–1053.
  1. Melissaropoulos, K, Bogdanos, D, Dimitroulas, T, Sakkas, L. I, Kitas, G. D, & Daoussis, D. Primary Sjögren’s Syndrome and Cardiovascular Disease. Current vascular pharmacology, 2020; 18(5), 447–454.
  1. Nuñez, P, García Mateo, S, Quera, R, & Gomollón, F. Inflammatory bowel disease and the risk of cardiovascular diseases. La enfermedad inflamatoria intestinal y los riesgos de enfermedad cardiovascular. Gastroenterologia y hepatologia, 2021; 44(3), 236–242.
  1. Gawałko M, Balsam P, Lodziński P, et al. Cardiac Arrhythmias in Autoimmune Diseases. Circulation journal 2020;84(5):685–94.
  1. Oishi Y, Manabe I. Organ System Crosstalk in Cardiometabolic Disease in the Age of Multimorbidity. Frontiers in cardiovascular medicine 2020;7:64.
  1. Oliveira CB, Kaplan MJ. Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus. Seminars in immunopathology 2022;44(3):309–24.
  1. Casian M, Jurcut C, Dima A, et al. Cardiovascular Disease in Primary Sjögren’s Syndrome: Raising Clinicians’ Awareness. Frontiers in immunology 2022;13:865373.
  1. Baik AH, Oluwole OO, Johnson DB, et al. Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies. Circulation research 2021;128(11):1780–801.
  1. Su HF, Shaker S, Kuang Y, et al. Phytochemistry and cardiovascular protective effects of Huang-Qi (Astragali Radix). Medicinal research reviews 2021;41(4):1999–2038.
  1. Pan L, Zhang XF, Wei WS, et al. The cardiovascular protective effect and mechanism of calycosin and its derivatives. Chinese journal of natural medicines 2020;18(12):907–15.
  1. Sui YB, Zhang KK, Ren YK, et al. The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure. Pharmaceutical biology 2020;58(1):1192–98.
  1. Huang H, Lai S, Wan Q, et al. Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein. Canadian journal of physiology and pharmacology 2016; 94(5):542–53.
  1. Wang T, Jiang X, Ruan Y, et al. The mechanism of action of the combination of Astragalus membranaceus and Ligusticum chuanxiong in the treatment of ischemic stroke based on network pharmacology and molecular docking. Medicine 2022;101(28):e29593.
  1. Liu CH, Tsai CH, Li TC, et al. Effects of the traditional Chinese herb Astragalus membranaceus in patients with poststroke fatigue: A double-blind, randomized, controlled preliminary study. Journal of ethnopharmacology 2016;194:954–62.
  1. Chen XY, Han HF, He ZY, Xu XG. Immune Mechanism, Gene Module, and Molecular Subtype Identification of Astragalus Membranaceus in the Treatment of Dilated Cardiomyopathy: An Integrated Bioinformatics Study. Evidence-based complementary and alternative medicine 2021:2252832.
  1. Zang Y, Wan J, Zhang Z, et al. An updated role of astragaloside IV in heart failure. Biomedicine & pharmacotherapy 2020;126:110012.
  1. Wan Y, Xu L, Wang Y, et al. Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome. European journal of pharmacology 2018;833:545–54.
  1. Xu X, Rui S, Chen C, et al. Protective effects of astragalus polysaccharide nanoparticles on septic cardiac dysfunction through inhibition of TLR4/NF-κB signaling pathway. International journal of biological macromolecules 2020;153:977–85.
  1. Zheng Q, Zhuang Z, Wang ZH, et al. Clinical and Preclinical Systematic Review of Astragalus Membranaceus for Viral Myocarditis. Oxidative medicine and cellular longevity 2020:1560353.
  1. Luo Z, Zhong L, Han X, et al. Astragalus membranaceus prevents daunorubicin-induced apoptosis of cultured neonatal cardiomyocytes: role of free radical effect of Astragalus membranaceus on daunorubicin cardiotoxicity. Phytotherapy research 2009;23(6):761–67.
  1. Cao Y, Shen T, Huang X, et al. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity. Oncotarget 2017;8(3):4837–48.
  1. Abushouk AI, Ismail A, Salem A, et al. Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity. Biomedicine & pharmacotherapy 2017;90:935–46.
  1. Li X, Guo X, Li J, et al. Preventing effect of astragalus polysaccharide on cardiotoxicity induced by chemotherapy of epirubicin: A pilot study. Medicine 2022;101(32):e30000.
  1. Peh A, O’Donnell JA, Broughton B, Marques FZ. Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword. Stroke 2022;53(5):1788–801.
  1. Li XY, Shen L, Ji HF. Astragalus alters gut-microbiota composition in type 2 diabetes mice: clues to its pharmacology. Diabetes, metabolic syndrome and obesity : targets and therapy 2019;12:771–78.
  1. Tian H, Lu J, He H, et al. The effect of Astragalus as an adjuvant treatment in type 2 diabetes mellitus: A (preliminary) meta-analysis. Journal of ethnopharmacology 2016;191:206–15.
  1. Li X, Zhao T, Gu J, et al. Intake of flavonoids from Astragalus membranaceus ameliorated brain impairment in diabetic mice via modulating brain-gut axis. Chinese medicine 2022;17(1):22.
  1. Wada J, Makino H. Innate immunity in diabetes and diabetic nephropathy. Nature reviews. Nephrology 2016;12(1):13–26.
  1. Pérez-Morales RE, Del Pino MD, Valdivielso JM, et al. Inflammation in Diabetic Kidney Disease. Nephron 2019;143(1):12–16.
  1. Li M, Wang W, Xue J, et al. Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy. Journal of ethnopharmacology 2011;133(2):412–19.
  1. Liu YH, Tian HM. Effect of Astragaulus membranaceus on diabetic nephropathy: a systematic review. Chin J Evidence-based Med 2007;7:715–27.
  1. Zhang HW, Lin ZX, Xu C, et al. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database Syst Rev 2014;(10):CD008369.
  1. Zhang L, Shergis JL, Yang L, et al. Astragalus membranaceus (Huang Qi) as adjunctive therapy for diabetic kidney disease: An updated systematic review and meta-analysis. Journal of ethnopharmacology 2019;239:111921.
  1. Li S, Yin XX, Su T, et al. Therapeutic effect of Astragalus and Angelica mixture on the renal function and TCM syndrome factors in treating stage 3 and 4 chronic kidney disease patients. Chinese journal of integrated traditional and Western medicine 2014;34(7):780–85.
  1. Shen P, Yang X, He L. Effect of Astragali and Angelica particle on proteinuria in Chinese patients with primary glomerulonephritis. Journal of traditional Chinese medicine 2016;36(3):299–306.
  1. Yuan H, Wu X, Wang X, Yuan C. Chinese herbal decoction astragalus and angelica exerts its therapeutic effect on renal interstitial fibrosis through the inhibition of MAPK, PI3K-Akt and TNF signaling pathways. Genes & diseases 2020;9(2):510–21.
  1. Song JY, Meng LQ, Li XM. Therapeutic application and prospect of Astragalus membranaceus and Angelica sinensis in treating renal microvascular lesions. Chinese journal of integrated traditional and Western medicine 2008;28(9):859–61.
  1. Tirelli U, Taibi R, Chirumbolo S. Post COVID syndrome: a new challenge for medicine. Eur Rev Med Pharmacol Sci 2021;25(12):4422–25.
  1. Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Curr Opin Neurobiol 2022;76:102608.
  1. König RS, Albrich WC, Kahlert CR, et al. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). Frontiers in immunology 2022;12:628741.
  1. Xu L, Xu XY, Hou XQ, et al. Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review. Metabolic brain disease 2020;35(1):83–93.
  1. Huang WC, Kuo KT, Bamodu OA, et al. Astragalus polysaccharide (PG2) Ameliorates Cancer Symptom Clusters, as well as Improves Quality of Life in Patients with Metastatic Disease, through Modulation of the Inflammatory Cascade. Cancers 2019;11(8):1054.
  1. Yeh YC, Doan LH, Huang ZY, et al. Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro. Frontiers in pharmacology 2022;12:765553.
  1. Zhang Q, Yue S, Wang W, et al. Potential Role of Gut Microbiota in Traditional Chinese Medicine against COVID-19. The American journal of Chinese medicine 2021;49(4):785–803.
  1. Alschuler L, Chiasson AM, Horwitz R, et al. Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease. Explore (NY) 2022;18(2):140–48.
  1. Luo H, Tang QL, Shang YX, et al. Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chinese journal of integrative medicine 2020;26(4):243–50.
  1. Adhikari B, Marasini BP, Rayamajhee B, et al. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review. Phytotherapy research 2021;35(3):1298–312.
  1. Tschöpe C, Ammirati E, Bozkurt B, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nature reviews. Cardiology 2021;18(3):169–93.
  1. Liu ZL, Liu ZJ, Liu JP, et al. Herbal medicines for viral myocarditis. Cochrane Database Syst Rev 2010;(7):CD003711.
  1. Zheng Q, Zhuang Z, Wang ZH, et al. Clinical and Preclinical Systematic Review of Astragalus Membranaceus for Viral Myocarditis. Oxidative medicine and cellular longevity 2020:1560353.
  1. Yang X, Zhu X, Tang X, et al. Astragalus polysaccharides meliorate cardiovascular dysfunction in iron-overloaded thalassemic mice. Experimental biology and medicine 2019;244(14):1202–09.
  1. Wang F, Lui J, Ye YF, et al. Astragalus polysaccharides improved the cardiac function in Sjogren’s syndrome model rats based on keap 1-Nrf2/ARE signalling pathway: a mechanism exploration. Chinese journal of integrated traditional and Western medicine 2014;34(5):566–74.
  1. Yang L, Han X, Yuan J, et al. Early astragaloside IV administration attenuates experimental autoimmune encephalomyelitis in mice by suppressing the maturation and function of dendritic cells. Life sciences 2020;249:117448.
  1. Guo S, Li Y, Su H, et al. Aidi injection as adjunctive treatment to gemcitabine-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis. Pharmaceutical biology 2021;59(1):1260–75.
  1. Dong J, Wang S, Gui Y, et al. Astragalus membranaceus (Huang Qi) for cancer-related fatigue: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101(3):e28633.
  1. Cheng M, Hu J, Zhao Y, et al. Efficacy and Safety of Astragalus-Containing Traditional Chinese Medicine Combined With Platinum-Based Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis. Frontiers in oncology 2021;11:632168.
  1. Shen L, Gwak SR, Cui ZY, et al. Astragalus-Containing Chinese Herbal Medicine Combined With Chemotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis. Frontiers in pharmacology 2021;12:587021.
  1. Wang SF, Wang Q, Jiao LJ, et al. Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis. Current oncology 2016;23(3):e188–95.
  1. Park JS, Sung HK, Kim SK, et al. Efficacy of Rubus coreanus Miq. and Astragalus membranaceus Bunge Extract for Postmenopausal Syndrome: A Randomised, Double-Blind, Placebo Comparative Clinical Trial. Evid Based Complement Alternat Med 2022;2022:4066054. 

Class

FRAZ Drug wastage

CLASStime: Medication wastage

In this article, Sue Frankland looks at the global problem of wastage of medications, including causes such as overprescribing and non-adherence. She also presents information from her master’s dissertation on how people understand, and respond to, medication expiration dates

Read more
Friday 1 March 2024, 12:35 AM
17 minutes to Read
More Class Articles

Latest news

What we know: Dengue fever in Samoa

26/04/2024

Fears allayed over proposed diabetes equipment changes

24/04/2024

Online retailer defies New Zealand drug regulations

24/04/2024

‘Overhyped’ claim 2247 deaths per year are due to medication errors

22/04/2024

Health NZ denies it's ordered a hiring freeze

22/04/2024

Hosted Content 2

Hydralyte

Recognising and managing dehydration with Hydralyte

Why recognising the signs of dehydration is important...

Read more
Brought to you by Care Pharmaceuticals
Thursday 1 February 2024, 08:30 AM
2 minutes to Read

Facebook

Pharmacy Today

Latest issue

PT April 2024 cover

April 2024

View all issues